CClinicalTrials.gg
Sign In
RecruitingNCT06644976Updated Oct 16, 2024

Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

An observational study in Osteoperosis, Femoral Neck Fractures and Anticoagulant Therapy, sponsored by Meir Hospital, Kfar Saba, Israel. Recruiting at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-16.

Sponsored by Meir Hospital, Kfar Saba, Israel · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

02

Conditions studied

  • Osteoperosis
  • Femoral Neck Fractures
  • Anticoagulant Therapy
03

In context

Hemorrhage

3,000 studies on the registry are indexed under Hemorrhage; 474 are open to participants now.

This study's planned enrollment of 100 is below the median of 150 across 893 observational studies indexed under Hemorrhage.

Browse Hemorrhage studies →

Lead sponsor

Meir Hospital, Kfar Saba, Israel is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with femoral neck fracture thattake noac and arrive at meir hospital and need surgery

Inclusion criteria

above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery

Exclusion criteria

-

Exclusion Criteria:

  • under 18 y.o
  • anti platelet therapy (aspirin is not included)
  • creatinine clearance under 50
  • active anti cancer therapy
  • ITP patients
  • non capable of making inform consent
  • patients which decide not to proceed with the expeirment
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • early surgery

    Procedure: femoral neck CRIF

  • late surgery

    Procedure: femoral neck CRIF

Interventions

  • Procedurefemoral neck CRIF

    femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

06

What researchers measure

Primary outcomes

  1. bleeding

    Time frame: 30 days

07

Study locations

1 of 1 sites recruiting
  • Meir Hospital
    Kfar Saba, 4428164, Israel
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06644976
Lead sponsor
Meir Hospital, Kfar Saba, Israel
Responsible party
Maron Talmore (Dr. meron pinchas talmor, Meir Hospital, Kfar Saba, Israel) — Principal investigator
First posted
Oct 16, 2024
Start date
Aug 20, 2024
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Oct 16, 2024

Study contacts

Meron pinchas talmor, medical doctor
Contact
merontalmor@gmail.com
+972523264183

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hemorrhage→

Other studies from this sponsor

Meir Hospital, Kfar Saba, Israel

Start the discussion